Medicinal Chemistry Research

, Volume 27, Issue 2, pp 429–441 | Cite as

Synthesis, biological evaluation, molecular docking, and ADMET studies of some isoxazole-based amides

  • Sushama Kauthale
  • Sunil Tekale
  • Manoj Damale
  • Jaiprakash Sangshetti
  • Rajendra Pawar
Original Research
  • 82 Downloads

Abstract

Some isoxazole-based amides were synthesized by the reaction of 3-(2-chlorophenyl)-5-methylisoxazole-4-carbonyl chloride with various aliphatic, aromatic and heterocyclic amines; characterized by analysis of spectroscopic data and evaluated for in vivo anti-inflammatory, ulcerogenic, and antimicrobial activity. Compounds A1, A7, and A10 were identified as the potent anti-inflammatory agents in carrageenan-induced albino rat paw edema assay exhibiting 92.85–93.57% edema inhibition after 5 h with lower ulcer index (2.5) than the standard diclofinac sodium (6.15). Antibacterial activity against the bacteria Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis was found to be good in comparison with the standard ampicillin in terms of minimum inhibitory concentration values. Anti-inflammatory activity results were supported by molecular docking—possible binding modes, interactions, and docking scores of titled compounds with the active site of cyclooxygenase-2 enzyme. In silico absorption, distribution, metabolism, and excretion–toxicity study was also performed to predict the preliminary pharmacological, pharmacokinetic, and toxicity profile of the synthesized anti-inflammatory agents suggesting that these derivatives have good oral drug like behavior and non-toxic nature.

Keywords

Molecular docking ADMET Anti-inflammatory Ulcerogenic Antibacterial. 

Notes

Acknowledgements

Authors are thankful to the Director, Sophisticated Analytical and Instrumentation Facility (SAIF), Panjab University Chandigarh (India) for providing spectral data and to the Director, Scan research laboratory, Bhopal for providing the results of biological activity.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Supplementary material

44_2017_2070_MOESM1_ESM.docx (25 kb)
Supplementary Information

References

  1. Abbas SE, Awadallah FM, Ibrahim NA, Gouda AM (2010) Novel substituted and fused pyrrolizine derivatives: synthesis, anti-inflammatory and ulcerogenecity studies. Eur J Med Chem 45:482–491CrossRefPubMedGoogle Scholar
  2. Antarkar SS, Chinwalla T, Bhatt N (1994) Anti-inflammatory activity of rubia cordifolia linn in rats. Ind J Pharm 15:185–188Google Scholar
  3. Collins AH (1976) Microbiological methods, 2nd edn. Butterworth, LondonGoogle Scholar
  4. Cruickshank R, Duguid JP, Marmion BP, Swain RHA eds (1975) Medicinal microbiology, 2nd edn. Churchill Livingstone, LondonGoogle Scholar
  5. Duraiswamy B, Mishra SK, Subhashini V, Dhanraj SA, Suresh B (2006) Studies on the antimicrobial potential of studies on the antimicrobial potential of Mahonia Mahonia leschenaultia. Ind J Pharm Sci 68:389–391CrossRefGoogle Scholar
  6. El-Henawy AA (2013) Synthesis, characterization, AMDET and docking studies of novel diclofenac derivatives containing phenylalanine moiety acting as selective inhibitors against cyclooxygenase (COX). Chem Mater Res 3:75–89Google Scholar
  7. El-Sayed NA, Awadallah FM, Ibrahim NA, El-Saadi MT (2010) Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives. Eur J Med Chem 45:3147–3154CrossRefPubMedGoogle Scholar
  8. Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714–3747CrossRefPubMedGoogle Scholar
  9. Finney DJ (1964) Statistical methods in biological assay. Charles Griffen & Company Limit, LondonGoogle Scholar
  10. Gierse JK, Koboldt CM, Walker MC, Siebeil K, Isakson PC (1999) Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339:607–614CrossRefPubMedPubMedCentralGoogle Scholar
  11. Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, Young LH, Johnson RS, Giordano FJ (2004) Cardiac myocyte-specific HIF-1 alpha deletion alters vascularization, energy availability, calcium flux and contractility in the normoxic heart. Faseb J 18:1138–1140CrossRefPubMedGoogle Scholar
  12. Kasahara Y, Hikino H, Tsurufuji S, Watanabe M, Ohuchi K (1985) Anti-inflammatory actions of ephedrines in acute inflammations. Planta Med 51:325–331CrossRefPubMedGoogle Scholar
  13. Kaur K, Kumar V, Sharma AK, Gupta GK (2014) Isoxazoline containing natural products as anticancer agents: a review. Eur J Med Chem 77:121–133CrossRefPubMedGoogle Scholar
  14. Khan ZK (1997) In: Proceedings of the international workshop UNIDO-CDRI: 210–211Google Scholar
  15. Krensky AM, Bennett WM, Vincenti F (2006) Textbook of pharmacology and therapeutics, 11th Ed. McGraw-Hill, New York, NYGoogle Scholar
  16. Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC (1996) Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384:644–648CrossRefPubMedGoogle Scholar
  17. Lagorce D, Sperandio H, Miteva M (2008) FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology project. BMC Bioinform 9(396):1–10Google Scholar
  18. Lipinski C, Lombardo F, Dominy B (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26CrossRefPubMedGoogle Scholar
  19. OECD (2001) Guideline for testing of chemicals-acute oral toxicity-acute toxic class method. OECD, ParisGoogle Scholar
  20. Pancholia S, Dhameliya TM, Shah P, Jadhavar PS, Sridevi JP, Yogeshwari P, Sriram D, Chakraborti AK (2016) Eur J Med Chem 116:187–199CrossRefPubMedGoogle Scholar
  21. Porto GG, Vasconcelos BC, Gomes AC, Albert D (2007) Evaluation of lidocaine and mepivacaine for inferior third molar surgery. Med Oral Patol Oral Cir Bucal 12:E60–E64PubMedGoogle Scholar
  22. Rajput SS, Patel SN, Jadhav NB (2015) Isoxazole—a basic aromatic heterocycle: synthesis, reactivity and biological activity. Int J Chem Tech Res 8:297–317Google Scholar
  23. Rangahanumaiah P, Rai RV, Saqhib A, Jothi L, Swamy MS, Karigar CS (2016) High-throughput screening by in silico molecular docking of Eryngium Foetidum (Linn.) bioactives for cylcooxygenase-2 inhibition. Pharmacogn Commn 6:232–237CrossRefGoogle Scholar
  24. Sangshetti J, Khan F, Chouthe R, Damale M, Shinde D (2014) Synthesis, docking and ADMET prediction of novel 5-((5-substituted-1-H-1, 2, 4-triazol-3-yl) methyl)-4, 5, 6, 7-tetrahydrothieno [3, 2-c] pyridine as antifungal agents. Chem Lett 25:1033–1038Google Scholar
  25. Saundane AR, Rudresh K, Satynarayan ND, Hiremath SP (1989) Ind J Pharm Sci 60:379–465Google Scholar
  26. Scott DE, Bayly AR, Abell C, Skidmore J (2016) Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat Rev Drug Discov 15:533–550CrossRefPubMedGoogle Scholar
  27. Vincent Z et al. (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 3:01–13Google Scholar
  28. Wen F, Jin H, Tao K, Hou T (2016) Design, synthesis and antifungal activity of novel furancarboxamide derivatives. Eur J Med Chem 120:244–251CrossRefPubMedGoogle Scholar
  29. Winter CA, Risely EA, Nuss GM (1962) Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544–547CrossRefPubMedGoogle Scholar
  30. Zimhony O, Cox JS, Welch JT, Vilcheze C, Jacobs WR (2000) Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of mycobacterium tuberculosis. Nat Med 6:1043–1047CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Sushama Kauthale
    • 1
  • Sunil Tekale
    • 1
  • Manoj Damale
    • 2
  • Jaiprakash Sangshetti
    • 3
  • Rajendra Pawar
    • 1
  1. 1.Department of ChemistryDeogiri College, Station RoadAurangabadIndia
  2. 2.Department of Pharmaceutical ChemistryShri. Bhagwan College of PharmacyAurangabadIndia
  3. 3.Y. B. Chavan College of PharmacyDr. Rafiq Zakaria CampusAurangabadIndia

Personalised recommendations